Editorial: Mutational signatures and immune response in cancer

Editorial: Mutational signatures and immune response in cancer

Bibliographic Details
Main Authors:	Ilias Georgakopoulos-Soares, Apostolos Zaravinos
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Genetics
Subjects:	mutational signatures tumor immune microenvironment biomarkers immune response cancer mutations
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2023.1215326/full

Similar Items

The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
by: Camille Moeckel, et al.
Published: (2023-04-01)

Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden
by: George Georgoulias, et al.
Published: (2022-10-01)

Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies
by: Paraskevi Vryza, et al.
Published: (2023-12-01)

Correlate tumor mutation burden with immune signatures in human cancers
by: Xiaosheng Wang, et al.
Published: (2019-01-01)

Immune signatures of the POLE mutation in endometrial carcinomas: a systematic study based on TCGA data and clinical cohort validation
by: Tieyan Wang, et al.
Published: (2023-11-01)

Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer
by: Hao Chen, et al.
Published: (2020-01-01)

A pathway-based mutation signature to predict the clinical outcomes and response to CTLA-4 inhibitors in melanoma
by: Qian Wang, et al.
Published: (2023-01-01)

A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer
by: Xiang Xu, et al.
Published: (2022-11-01)

A KRAS-Associated Signature for Prognostic, Immune and Chemical Anti-Cancer Drug-Response Prediction in Colon Cancer
by: Kangjia Luo, et al.
Published: (2022-06-01)

Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer
by: Zewei Zhuo, et al.
Published: (2022-02-01)

Pan-Cancer Analysis for Immune Cell Infiltration and Mutational Signatures Using Non-Negative Canonical Correlation Analysis
by: Je-Keun Rhee
Published: (2022-06-01)

Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer
by: Xinyu Li, et al.
Published: (2020-09-01)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
by: Qian Song, et al.
Published: (2019-03-01)

Identification of an Immune-Related Signature Predicting Survival Risk and Immune Microenvironment in Gastric Cancer
by: Shuang Dai, et al.
Published: (2021-11-01)

Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis
by: Stavroula Baritaki, et al.
Published: (2023-10-01)

Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma
by: Wengang Zhang, et al.
Published: (2022-11-01)

Immune Cytolytic Activity and Strategies for Therapeutic Treatment
by: Stephanie Agioti, et al.
Published: (2024-03-01)

Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer
by: Hongfei Zhang, et al.
Published: (2022-08-01)

Strand asymmetries across genomic processes
by: Camille Moeckel, et al.
Published: (2023-01-01)

Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
by: Si Yang, et al.
Published: (2019-12-01)

Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden
by: Jan Budczies, et al.
Published: (2018-12-01)

Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
by: Na Li, et al.
Published: (2021-11-01)

Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
by: Ying Xu, et al.
Published: (2021-01-01)

A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma
by: Huaide Qiu, et al.
Published: (2020-12-01)

A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients
by: Xilin Hu, et al.
Published: (2023-06-01)

Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
by: Li-Zhi Luo, et al.
Published: (2023-05-01)

Identification and validation of a tumor mutation burden-related signature combined with immune microenvironment infiltration in adrenocortical carcinoma
by: Yong Luo, et al.
Published: (2022-05-01)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
by: Sijin Sun, et al.
Published: (2020-08-01)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
by: Mengjing Cui, et al.
Published: (2022-01-01)

Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy
by: Annie Borch, et al.
Published: (2023-03-01)

A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy
by: Zhirui Zeng, et al.
Published: (2022-09-01)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
by: Julie Decock, et al.
Published: (2023-05-01)

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma
by: Junyu Huo, et al.
Published: (2020-11-01)

Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC
by: Wei Chong, et al.
Published: (2021-03-01)

Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma
by: Xinqing Lin, et al.
Published: (2020-11-01)

A novel immune signature predicts immunotherapy responsiveness and reveals the landscape of the tumor immune microenvironment in head and neck squamous cell carcinoma
by: Qiwei Wang, et al.
Published: (2022-11-01)

Editorial: Gastrointestinal cancer immune response and immune related adverse effects
by: Ti Wen, et al.
Published: (2022-10-01)

The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma
by: Lijiang He, et al.
Published: (2021-05-01)

Construction of an immune-related signature with prognostic value for colon cancer
by: Yunxia Lv, et al.
Published: (2021-05-01)

PathwayTMB: A pathway-based tumor mutational burden analysis method for predicting the clinical outcome of cancer immunotherapy
by: Xiangmei Li, et al.
Published: (2023-12-01)